Fox Rothschild’s Data Breach 411 iPhone Application Named One of BigLaw’s Best New Mobile Apps

Fox Rothschild LLP is excited to announce that Data Breach 411, an iPhone app that delivered a comprehensive resource on state breach notification statutes and related materials, was named one of BigLaw’s best new mobile apps for 2014.   View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Mobile Enforcement Continues to Be APPealing to the FTC

By | Ad Law Access | April 2, 2014
On March 28, 2014, the FTC announced two new mobile app settlements – with Fandango and Credit Karma – based on allegations that the companies failed to secure the transmission of consumers’ sensitive personal information collected via their mobile apps and misrepresented the security precautions that the companies took for each app. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Mobile Medical App Regulations On the Move – Proposed Bills to Further Alter the Regulatory Landscape of Mobile Medical Apps

Apple’s apps store lists close to a 100,000 health apps.  Together with wearable technology, direct-to-consumer testing services, and greater consumer participation in the decision to purchase health insurance, the healthcare market in the United States is undergoing a significant transformation. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

Mobile Medical App Regulations On the Move – Proposed Bills to Further Alter the Regulatory Landscape

By | FDA Law Update | April 1, 2014
Apple’s apps store lists close to a 100,000 health apps.  Together with wearable technology, direct-to-consumer testing services, and greater consumer participation in the decision to purchase health insurance, the healthcare market in the United States is undergoing a significant transformation. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus

FDA Delivers Its First Mobile Medical App Inquiry

The Food and Drug Administration has taken its first action against a mobile app maker for failure to obtain pre-marketing clearance. Late last week the FDA sent a letter to Biosense Technologies Private Limited, asking the company to either identify an FDA clearance for its uChek urine analyzer app or explain why it does not believe that FDA clearance is required. View Full Post
Tweet Like LinkedIn LinkedIn Google Plus